ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients.

Dear Editor,The novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) enters human cells by binding to the membrane bound angiotensin converting enzyme-2 (ACE-2) [1]. Angiotensin conve...